Cargando…

Globally deimmunized lysostaphin evades human immune surveillance and enables highly efficacious repeat dosing

There is a critical need for novel therapies to treat methicillin-resistant Staphylococcus aureus (MRSA) and other drug-resistant pathogens, and lysins are among the vanguard of innovative antibiotics under development. Unfortunately, lysins’ own microbial origins can elicit detrimental antidrug ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hongliang, Brooks, Seth A., Eszterhas, Susan, Heim, Spencer, Li, Liang, Xiong, Yan Q., Fang, Yongliang, Kirsch, Jack R., Verma, Deeptak, Bailey-Kellogg, Chris, Griswold, Karl E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467700/ https://www.ncbi.nlm.nih.gov/pubmed/32917596 http://dx.doi.org/10.1126/sciadv.abb9011

Ejemplares similares

Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance
por: Blazanovic, Kristina, et al.
Publicado: (2015)

Optimization algorithms for functional deimmunization of therapeutic proteins
por: Parker, Andrew S, et al.
Publicado: (2010)

Mapping the Pareto Optimal Design Space for a Functionally Deimmunized Biotherapeutic Candidate
por: Salvat, Regina S., et al.
Publicado: (2015)

Deimmunization of flagellin for repeated administration as a vaccine adjuvant
por: Khim, Koemchhoy, et al.
Publicado: (2021)

Building blocks and blueprints for bacterial autolysins
por: Mitchell, Spencer J., et al.
Publicado: (2021)

Design and Engineering of Deimmunized Vaccinia Viral Vectors
por: Song, Kevin, et al.
Publicado: (2020)

Mutagenic Deimmunization of Diphtheria Toxin for Use in Biologic Drug Development
por: Schmohl, Joerg U., et al.
Publicado: (2015)

Lysostaphin: an enzymatic approach to staphylococcal disease. 3. Combined lysostaphin-methicillin therapy of established staphylococcal abscesses in mice.
por: Dixon, R. E., et al.
Publicado: (1968)

Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice
por: Agustín-Pavón, Carmen, et al.
Publicado: (2016)

Deimmunization of protein therapeutics – Recent advances in experimental and computational epitope prediction and deletion
por: Zinsli, Léa V., et al.
Publicado: (2020)

Structural and Functional Insights Into Lysostaphin–Substrate Interaction
por: Tossavainen, Helena, et al.
Publicado: (2018)

Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticity
por: Lai, Jennifer I., et al.
Publicado: (2020)

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications
por: Mett, Vadim, et al.
Publicado: (2021)

Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications
por: Bastos, Maria do Carmo de Freire, et al.
Publicado: (2010)

The Influence of Dimerization on the Pharmacokinetics and Activity of an Antibacterial Enzyme Lysostaphin
por: Grishin, Alexander V., et al.
Publicado: (2019)

A Simple Protocol for the Determination of Lysostaphin Enzymatic Activity
por: Grishin, Alexander V., et al.
Publicado: (2020)

Towards conformational fidelity of a quaternary HIV-1 epitope: computational design and directed evolution of a minimal V1V2 antigen
por: Lai, Jennifer I, et al.
Publicado: (2018)

Development of a Deimmunized Bispecific Immunotoxin dDT2219 against B-Cell Malignancies
por: Schmohl, Joerg U., et al.
Publicado: (2018)

Lysostaphin: an enzymatic approach to staphylococcal disease. II. In vivo studies.
por: Schaffner, W., et al.
Publicado: (1967)

Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies.
por: Schaffner, W., et al.
Publicado: (1967)

Anti-staphylococcal activities of lysostaphin and LytM catalytic domain
por: Sabala, Izabela, et al.
Publicado: (2012)

Cloning, Expression, and Purification of Recombinant Lysostaphin From Staphylococcus simulans
por: Farhangnia, Leila, et al.
Publicado: (2014)

Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulans
por: Sabala, Izabela, et al.
Publicado: (2014)

Clinical efficacy of intravaginal recombinant lysostaphin administration on endometritis in sows
por: Ye, Guizi, et al.
Publicado: (2021)

Antibacterial and Anti-Biofilm Properties of Diopside Powder Loaded with Lysostaphin
por: Kudinova, Alina, et al.
Publicado: (2023)

New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization
por: Khlusevich, Yana, et al.
Publicado: (2022)

In Vitro and in Vivo Antistaphylococcal Activity Determination of the New Recombinant Lysostaphin Protein
por: Abtahi, Hamid, et al.
Publicado: (2016)

Structural bases of peptidoglycan recognition by lysostaphin SH3b domain
por: Mitkowski, Paweł, et al.
Publicado: (2019)

Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37
por: Sadeghi, Somayeh, et al.
Publicado: (2019)

A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform
por: Nour El-Din, Hanzada T., et al.
Publicado: (2020)

Recombinant Lysostaphin Protects Mice from Methicillin-Resistant Staphylococcus aureus Pneumonia
por: Chen, Chen, et al.
Publicado: (2014)

Two site recognition of Staphylococcus aureus peptidoglycan by lysostaphin SH3b
por: Gonzalez-Delgado, Luz S., et al.
Publicado: (2019)

Design and High Expression of Non-glycosylated Lysostaphins in Pichia pastoris and Their Pharmacodynamic Study
por: Shen, Wenluan, et al.
Publicado: (2021)

Draft Genome Sequences of Lysostaphin-Resistant (K07-204) and Lysostaphin-Susceptible (K07-561) Staphylococcus aureus Sequence Type 72 Strains Isolated from Patients in South Korea
por: Batool, Nayab, et al.
Publicado: (2020)

Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Deimmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins
por: Grinberg, Yehudit, et al.
Publicado: (2017)

Development of a novel fully functional coagulation factor VIII with reduced immunogenicity utilizing an in silico prediction and deimmunization approach
por: Winterling, Karina, et al.
Publicado: (2021)

Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression
por: Littmann, Marie, et al.
Publicado: (2009)

The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress
por: Liu, Yanan, et al.
Publicado: (2022)

Cloning and expression of Staphylococcus simulans lysostaphin enzyme gene in Bacillus subtilis WB600
por: Far, Babak Elyasi, et al.
Publicado: (2021)

Zinc-finger nickase-mediated insertion of the lysostaphin gene into the beta-casein locus in cloned cows
por: Liu, Xu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lfj29ck0p8turd9c4paon1ctth